المؤلفون: Molés-Poveda P, Comis LE, Joe GO, Mitchell SA, Pichard DC, Rosenstein RK, Solomon B, Pavletic SZ, Cowen EW

المصدر: Archives of physical medicine and rehabilitation
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

مصطلحات موضوعية: Graft vs host disease, Occupational therapy, Physical therapy, Rehabilitation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f9a845e6d831f76a77575d9cb42b5364
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13893

المؤلفون: May D; Acadia Pharmaceuticals, San Diego, CA, USA. dmay@ACADIA-Pharm.com., Kponee-Shovein K; Analysis Group, Inc, Boston, MA, USA., Neul JL; Vanderbilt Kennedy Center, Nashville, TN, USA.; Vanderbilt University Medical Center, Nashville, TN, USA., Percy AK; Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Mahendran M; Analysis Group, Inc, Boston, MA, USA., Downes N; Analysis Group, Inc, Boston, MA, USA., Chen G; Analysis Group, Inc, Boston, MA, USA., Watson T; Analysis Group, Inc, Boston, MA, USA., Pichard DC; International Rett Syndrome Foundation, Cincinnati, OH, USA., Kennedy M; International Rett Syndrome Foundation, Cincinnati, OH, USA., Lefebvre P; Analysis Group, Inc, Boston, MA, USA.

المصدر: Journal of neurodevelopmental disorders [J Neurodev Disord] 2024 Jul 26; Vol. 16 (1), pp. 42. Date of Electronic Publication: 2024 Jul 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101483832 Publication Model: Electronic Cited Medium: Internet ISSN: 1866-1955 (Electronic) Linking ISSN: 18661947 NLM ISO Abbreviation: J Neurodev Disord Subsets: MEDLINE

مواضيع طبية MeSH: Rett Syndrome*/physiopathology , Rett Syndrome*/therapy , Rett Syndrome*/complications, Humans ; Female ; United States/epidemiology ; Adult ; Child ; Adolescent ; Retrospective Studies ; Young Adult ; Child, Preschool ; Severity of Illness Index ; Registries ; Infant ; Databases, Factual

المؤلفون: John L; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Singh G; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dombi E; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Wolters PL; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Martin S; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Baldwin A; Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Bernstein J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Whitcomb P; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Pichard DC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dufek A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gillespie A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Heisey K; Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Bornhorst M; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Fisher MJ; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Weiss BD; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Kim A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Widemann BC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Gross AM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

المصدر: Clinical trials (London, England) [Clin Trials] 2024 Apr; Vol. 21 (2), pp. 189-198. Date of Electronic Publication: 2023 Oct 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 101197451 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-7753 (Electronic) Linking ISSN: 17407745 NLM ISO Abbreviation: Clin Trials Subsets: MEDLINE

مواضيع طبية MeSH: Neurofibroma, Plexiform*/drug therapy , Neurofibromatosis 1*/drug therapy, Child ; Humans ; Prospective Studies ; Reproducibility of Results

المؤلفون: Cannon A; School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.; InformedDNA, Inc., St. Petersburg, FL, USA., Sarin KY; Department of Dermatology, Stanford Medicine, Stanford University, Redwood City, CA, USA., Petersen AK; Randall Children's Hospital, Portland, OR, USA., Pichard DC; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases, NIH, Bethesda, MD, USA.; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., Wolters PL; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., Erickson G; Neurofibromatosis Network, Wheaton, IL, USA., Lessing AJ; Neurofibromatosis Northeast, Burlington, MA, USA., Li P; School of Nursing, University of Alabama at Birmingham, Birmingham, AL, USA., Röhl C; NF Kinder, Vienna, Austria., Rosser T; Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Widemann BC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA., Blakeley JO; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Plotkin SR; Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, MA, USA.

المصدر: Clinical trials (London, England) [Clin Trials] 2024 Feb; Vol. 21 (1), pp. 67-72. Date of Electronic Publication: 2023 Jun 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 101197451 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1740-7753 (Electronic) Linking ISSN: 17407745 NLM ISO Abbreviation: Clin Trials Subsets: MEDLINE

مواضيع طبية MeSH: Neurofibromatosis 1*/therapy , Neurofibromatosis 1*/pathology , Neurofibroma*/pathology , Skin Neoplasms*/therapy , Skin Neoplasms*/pathology, Child ; Adolescent ; Humans ; Emotions ; Surveys and Questionnaires

المؤلفون: Fertitta L; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France.; INSERM U955 , 94010, Créteil, France., Bergqvist C; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France., Sarin KY; Department of Dermatology, Stanford Medicine, Stanford University, Redwood City, CA, USA., Plotkin SR; Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, MA, USA., Moertel C; Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA., Petersen AK; Department of Rehabilitation and Development, Randall Children's Hospital at Legacy Emanuel Medical Center, Portland, OR, 97227, USA., Cannon A; School of Health Professions, University of Alabama at Birmingham, Birmingham, AL, USA.; InformedDNA, Inc., St Petersburg, FL, USA., Berman Y; Clinical Genetics, Royal North Shore Hospital, St Leonards, NSW, Australia and University of Sydney, Sydney, Australia., Pichard DC; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases.; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute; National Institutes of Health, Bethesda, MD, USA., Röhl C; NF Patients United - Global Network of NF Support Groups, Vienna, Austria., Lessing A; Neurofibromatosis Northeast, Burlington, MA, USA., Brizion B; Centre de documentation de l'AP-HP, AP-HP, Paris, France., Peiffer B; Department of Dermatology., Ravaud P; Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.; Université de Paris, CRESS, INSERM, INRA , F-75004 Paris, France., Tran VT; Center for Clinical Epidemiology, Hôtel-Dieu Hospital (AP-HP), Paris, France.; Université de Paris, CRESS, INSERM, INRA , F-75004 Paris, France., Armand ML; Department of Dermatology., Moryousef S; Department of Dermatology., Ferkal S; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France., Jannic A; Department of Dermatology., Ezzedine K; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France.; Université Paris-Est Créteil (UPEC), 94010 Créteil, France., Wolkenstein P; Department of Dermatology.; INSERM, Centre d'Investigation Clinique 1430; National Referral Center for Neurofibromatoses, -Henri-Mondor Hospital, Assistance Publique-Hôpitaux Paris (AP-HP) , 94010 Créteil, France.; INSERM U955, 94010, Créteil, France.; Université Paris-Est Créteil (UPEC), 94010 Créteil, France.

مؤلفون مشاركون: Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) international collaboration

المصدر: The British journal of dermatology [Br J Dermatol] 2024 Jan 23; Vol. 190 (2), pp. 216-225.

نوع المنشور: Systematic Review; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Neurofibroma* , Neurofibromatosis 1* , Skin Neoplasms*, Humans ; Delphi Technique ; Research Design

المؤلفون: Naik HB; Department of Dermatology, University of California, San Francisco, California. Electronic address: Haley.Naik@ucsf.edu., Pichard DC; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland., Schwartz DM; Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., O'Brien M; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland., Masciocchi M; Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland., Thompson J; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland., Sen HN; Clinical and Translational Immunology Unit, Laboratory of Immunology, National Eye Institute, Bethesda, Maryland., Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Mitchell SA; Division of Cancer Control and Population Sciences, Outcomes Research Branch, National Cancer Institute, Rockville, Maryland., de Jesus AA; Translational Autoinflammatory Diseases Section (TADS), LCIM, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., McCalmont TH; Department of Dermatology, University of California, San Francisco, California; Department of Pathology, University of California, San Francisco, California., Dey A; Section of Inflammation and Cardiovascular Diseases, National Institute of Heart, Lung and Blood Diseases, Bethesda, Maryland., Rosenstein RK; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland., Deng Z; Biodata Mining and Discovery Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland., Goldbach-Mansky R; Translational Autoinflammatory Diseases Section (TADS), LCIM, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Mehta NN; Section of Inflammation and Cardiovascular Diseases, National Institute of Heart, Lung and Blood Diseases, Bethesda, Maryland., Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland.

المصدر: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2022 Dec; Vol. 87 (6), pp. 1380-1383. Date of Electronic Publication: 2022 Sep 16.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Psoriasis*/drug therapy , Dermatologic Agents*/therapeutic use , Skin Diseases, Vesiculobullous*/drug therapy, Humans ; Interleukin 1 Receptor Antagonist Protein/adverse effects

المؤلفون: Barron KS; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Aksentijevich I; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Deuitch NT; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Stone DL; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Hoffmann P; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Videgar-Laird R; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Soldatos A; National Institute of Neurological Diseases and Strokes, National Institutes of Health (NIH), Bethesda, MD, United States., Bergerson J; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Toro C; Undiagnosed Disease Program, National Institutes of Health (NIH), Bethesda, MD, United States., Cudrici C; National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Nehrebecky M; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Romeo T; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Jones A; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Boehm M; National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Kanakry JA; National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Dimitrova D; National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Calvo KR; Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Bethesda, MD, United States., Alao H; National Institute of Digestive Diseases and Kidney Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Kapuria D; National Institute of Digestive Diseases and Kidney Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Ben-Yakov G; National Institute of Digestive Diseases and Kidney Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Pichard DC; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Hathaway L; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Brofferio A; National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), Bethesda, MD, United States., McRae E; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Moura NS; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Schnappauf O; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Rosenzweig S; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Heller T; National Institute of Digestive Diseases and Kidney Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Cowen EW; National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Kastner DL; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States., Ombrello AK; National Human Genome Research Institute, National Institutes of Health (NIH), Bethesda, MD, United States.

المصدر: Frontiers in immunology [Front Immunol] 2022 Jan 10; Vol. 12, pp. 811473. Date of Electronic Publication: 2022 Jan 10 (Print Publication: 2021).

نوع المنشور: Journal Article; Observational Study; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Adenosine Deaminase/*deficiency , Intercellular Signaling Peptides and Proteins/*deficiency, Adolescent ; Adult ; Aged ; COVID-19/metabolism ; Child ; Child, Preschool ; Cohort Studies ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Infant ; Longitudinal Studies ; Male ; Middle Aged ; Tumor Necrosis Factor Inhibitors/metabolism ; Young Adult

المؤلفون: Cannon A; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston. ashleycannon@uabmc.edu., Pichard DC; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Wolters PL; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Adsit S; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Erickson G; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Lessing AJ; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Li P; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Narmore W; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Röhl C; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Rosser T; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Widemann BC; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Blakeley JO; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston., Plotkin SR; From the Department of Genetics (A.C., W.N.) and School of Nursing (P.L.), University of Alabama at Birmingham; Dermatology Branch, National Institutes of Arthritis, Musculoskeletal, and Skin Diseases (D.C.P.), and Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute (D.C.P., P.L.W., B.C.W.), NIH, Bethesda, MD; Children's Tumor Foundation (S.A.), New York, NY; Neurofibromatosis Network (G.E.), Wheaton, IL; Neurofibromatosis Northeast (A.J.L.), Burlington, MA; NF Kinder (C.R.), Vienna, Austria; Children's Hospital Los Angeles (T.R.); Keck School of Medicine (T.R.), University of Southern California, Los Angeles; Neurology (J.O.B.), Johns Hopkins School of Medicine, Baltimore, MD; and Department of Neurology and Cancer Center (S.R.P.), Massachusetts General Hospital, Boston.

مؤلفون مشاركون: REiNS International Collaboration

المصدر: Neurology [Neurology] 2021 Aug 17; Vol. 97 (7 Suppl 1), pp. S15-S24. Date of Electronic Publication: 2021 Jul 06.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials as Topic*, Neurofibroma/*therapy , Neurofibromatoses/*therapy , Neurofibromatosis 1/*metabolism, Adolescent ; Adult ; Connective Tissue Diseases/therapy ; Humans ; Neurilemmoma/therapy ; Skin Neoplasms/therapy ; Surveys and Questionnaires

SCR Disease Name: Schwannomatosis

المؤلفون: Kim H; Juvenile Myositis Pathogenesis and Therapeutics Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA hanna.kim@nih.gov.; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Dill S; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., O'Brien M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Vian L; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Li X; Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Manukyan M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Jain M; Rehabilitation Medicine Department, Physical Therapy Section, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Adeojo LW; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., George J; Clinical Pharmacokinetics Research Unit, Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Perez M; Pediatric Rheumatology, Cook Children's Medical Center, Fort Worth, Texas, USA., Grom AA; Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Sutter M; Department of Rheumatology, Children's Hospital Colorado, Aurora, Colorado, USA.; Pediatrics Rheumatology, University of Colorado Denver, Denver, Colorado, USA., Feldman BM; Division of Rheumatology, Hospital for Sick Children, Toronto, Ontario, Canada.; Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada., Yao L; Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Maryland, USA., Millwood M; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Brundidge A; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Pichard DC; Dermatology Branch, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Cowen EW; Dermatology Branch, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Shi Y; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Lu S; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Tsai WL; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Gadina M; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA., Rider LG; Environmental Autoimmunity Group, NIEHS/NIH/DHHS, Bethesda, Maryland, USA., Colbert RA; Pediatric Clinical Trials Unit, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.

المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Mar; Vol. 80 (3), pp. 406-408. Date of Electronic Publication: 2020 Aug 25.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

مواضيع طبية MeSH: Azetidines*/pharmacology , Azetidines*/therapeutic use , Dermatomyositis*/drug therapy, Humans ; Janus Kinase 1 ; Janus Kinase 2 ; Janus Kinases ; Purines/therapeutic use ; Pyrazoles ; Sulfonamides

المؤلفون: Smith ZI; School of Medicine, Wayne State University, Detroit, Michigan., Rosenstein RK; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland., Banerjee S; Walden University, Minneapolis, Minnesota., Pichard DC; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland., Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

المصدر: JAMA dermatology [JAMA Dermatol] 2020 May 01; Vol. 156 (5), pp. 589-590.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/physiopathology , Quality of Life*, Humans ; Chronic Disease ; Cohort Studies ; Hematopoietic Stem Cell Transplantation ; Ethnic and Racial Minorities